2014 International Meeting for Autism Research

May 14 - 17, 2014

Novartis, Roche, Shire: Research grants

3C Institute: Employment (full or part-time)

Curemark LLC: Research grants

Bracket: Consulting fees
Coronado: Consulting fees
BioMarin: Consulting fees
Roche: Consulting fees and Research grants
Neuren: Consulting fees
Pfizer: Research grants
Shire: Research grants
NIMH: Research grants
Tourette Syndrome Association: Research grants
Roche Pharmaceuticals: Consulting fees and Research grants
Pfizer Pharmaceuticals: Research grants
Biomarin Pharmaceuticals: Consulting fees
Coronado Pharmaceuticals: Consulting fees
Neuren Pharmaceuticals: Consulting fees
Shire Pharmaceuticals: Research grants
NIH: Research grants
Tourette Syndrome Association: Research grants and Speakers' bureau
Pfizer Pharmaceuticals: Research grants
Biomarin Pharmaceuticals: Consulting fees
Coronado Pharmaceuticals: Consulting fees
Neuren Pharmaceuticals: Consulting fees
Shire Pharmaceuticals: Research grants
Bracket : Consulting fees

F. Hoffmann-La Roche: Employment (full or part-time)

Autism Speaks: Research grants

Chemocentryx: Stock

Hoffmann-La Roche Inc.: Research grants

Experiad Solutions: Consulting fees

IxDx Ltd.: Stock
David Skuse: Stock

Stemina Biomarker Discovery: Employment (full or part-time)

SIMmersion LLC: Research grants

Psybrain, Inc: member of the Scientific Advisory Board

Neuren Pharmaceuticals: Consulting fees

Simons Foundation: Employment (full or part-time)

Roche: Employment (full or part-time)

Lineagen: Consulting fees

Vanderbilt University: Receipt of royalties

Pfizer Inc.: Employment (full or part-time)

Pfizer: Consulting fees
Takea: Consulting fees
Roche: Consulting fees
BMS: Consulting fees
Lilly: Consulting fees
Janssen: Research grants